Stock market today: S&P 500 climbs as health care, tech gain; Nvidia earnings loom
LAKEWOOD, Colo. - Mesa Laboratories, Inc. (NASDAQ:MLAB) announced Thursday that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock, maintaining its impressive 23-year streak of consecutive dividend payments. The current dividend yield stands at 0.64%.
The dividend will be payable on September 15, 2025, to shareholders of record at the close of business on August 29, 2025, according to a company press release.
Mesa Laboratories describes itself as a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in pharmaceutical, healthcare and medical device industries.
The company’s products and services aim to help customers ensure product integrity, increase patient and worker safety, and improve quality of life worldwide.
Mesa Laboratories trades on the Nasdaq stock exchange under the ticker symbol MLAB. The quarterly dividend announcement represents a continuation of the company’s regular dividend payments to shareholders.
In other recent news, Mesa Laboratories, Inc. announced a change in its auditing firm following the merger of its previous auditor, Moss Adams LLP, with Baker Tilly US, LLP. This merger led Moss Adams to resign, and Mesa’s Board of Directors has approved Baker Tilly as the new independent registered public accounting firm. There were no disagreements or adverse opinions in Moss Adams’ audit report for the fiscal year ending March 31, 2025. Additionally, Mesa Laboratories has declared a quarterly dividend of $0.16 per share, scheduled for payment on June 16, 2025, to shareholders of record as of May 30, 2025. The company has issued forward-looking statements regarding revenue growth and operational results, cautioning investors about the risks and uncertainties that might affect actual outcomes. These statements cover various topics, including profit margins and market conditions, and are intended to provide insight into Mesa’s future expectations. Mesa Laboratories regularly communicates financial developments to its shareholders and the broader market.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.